In this podcast, Dr. Valentin Furster discusses a groundbreaking study on the role of oxidized phospholipids in calcific aortic valvular disease, highlighting their significant association with disease prevalence and progression. The findings suggest that targeting oxidized phospholipids, not just the Lp(a) particle, could offer a promising new therapeutic approach to treat this condition.
Information
- Show
- FrequencyUpdated Daily
- PublishedDecember 9, 2024 at 3:00 PM UTC
- Length10 min
- RatingClean